biotech

Latest news and analysis on biotech

Yesterday's Australia Biotech Invest 2014 conference in Melbourne rather optimistically considered whether the flight from resources stocks may benefit the...

John Robertson
John Robertson
PortfolioDirect

3 short-term Biotech plays

Livewire Equities
Livewire Equities
Livewire

Bionomics (BNO) - Merck thinks BNC375 is unforgettable, too | Analyst: Stuart Roberts | Rating: Buy TP:$1.10 | Bionomics has secured a new research...

Mathan Somasundaram
Deep Data Analytics

David Merkel from the Aleph Blog says It is wise to avoid the area of the market where issuance is well above average

Livewire News
Livewire News
Livewire

The US transport sector and the biotech sector are two extremes of the US market

John Robertson
John Robertson
PortfolioDirect

There's some interesting action going on in US equities today

Jay Soloff
Jay Soloff
Argonath Financial

At least one patient with diabetic limb ulcers will be pleased that they participated in Osprey Medical's (ASX:OSP) Limb Recovery trial

Matthijs Smith
Matthijs Smith
Canaccord Genuity Australia

After Prana (ASX:PBT) announced a result we would rather forget from their Alzheimer's drug, the biotech sector closed down 7.9% last week

Matthijs Smith
Matthijs Smith
Canaccord Genuity Australia

dorsaVi (ASX:DVL) is walking around with an impressive update on the commercialisation of its movement products

Matthijs Smith
Matthijs Smith
Canaccord Genuity Australia

Last week, the small end of town was where all the action was in biotech-land with Biotron (ASX:BIT) up 97%, newcomer Innate Therapeutics (ASX:IIL) up 33% and...

Matthijs Smith
Matthijs Smith
Canaccord Genuity Australia
81-90 of 92
The 10th annual Livewire Live 2026

One room. One day. The minds that move markets.

22 September 2026 Art Gallery of NSW, Sydney

Register Now